Michael Anderson v. HHS - Influenza, dermatomyositis (2020)
Case summary [AI summaries can sometimes make mistakes]
Michael Anderson filed a petition for compensation under the National Vaccine Injury Compensation Program on July 28, 2017. He alleged that he developed dermatomyositis after receiving the influenza and Tdap vaccines on November 17, 2015.
The respondent denied that the immunizations caused his injury. The parties, however, reached a settlement agreement.
On January 30, 2020, they filed a joint stipulation agreeing to settle the case. As part of the settlement, the respondent agreed to issue a lump sum payment of $50,527.64, payable to Michael Anderson, as compensation for all damages.
Special Master Mindy Michaels Roth adopted the joint stipulation and awarded compensation in the agreed-upon amount and terms. The decision was filed on January 30, 2020.
Petitioner's counsel was Shealene Mancuso, Esq., of Muller Brazil, LLP. Respondent's counsel was Mark Hellie, Esq., of the US Department of Justice.
Theory of causation
Petitioner Michael Anderson alleged that he developed dermatomyositis after receiving the influenza and Tdap vaccines on November 17, 2015. The respondent denied causation. The parties reached a joint stipulation to settle the case, and the Special Master adopted this stipulation. The public decision does not describe the specific theory of causation, any medical experts, or the mechanism of injury. The settlement resulted in a lump sum award of $50,527.64 to petitioner Michael Anderson. The decision was filed on January 30, 2020, by Special Master Mindy Michaels Roth. Petitioner's counsel was Shealene Mancuso, Esq., and respondent's counsel was Mark Hellie, Esq.
Source PDFs
USCOURTS-cofc-1_17-vv-01017